Risk for a composite heart failure outcome was reduced by 22% with oral semaglutide in heart failure patients with type 2 diabetes and certain comorbidities, a secondary analysis of a ...
A study presented at the European Society of Cardiology (ESC) Congress 2025 by German and US cardiologists shows that patients with heart failure and preserved ejection fraction (HFpEF) who were ...
A new Scientific Statement from the Heart Failure Society of America (HFSA) challenges longstanding ambiguity in the classification and treatment of heart failure with mildly reduced ejection fraction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results